Suppr超能文献

小鼠角膜新生血管化的碱烧伤损伤模型。

An alkali-burn injury model of corneal neovascularization in the mouse.

作者信息

Anderson Chastain, Zhou Qinbo, Wang Shusheng

机构信息

Department of Cell and Molecular Biology, Tulane University; Department of Ophthalmology, Tulane University;

出版信息

J Vis Exp. 2014 Apr 7(86):51159. doi: 10.3791/51159.

Abstract

Under normal conditions, the cornea is avascular, and this transparency is essential for maintaining good visual acuity. Neovascularization (NV) of the cornea, which can be caused by trauma, keratoplasty or infectious disease, breaks down the so called 'angiogenic privilege' of the cornea and forms the basis of multiple visual pathologies that may even lead to blindness. Although there are several treatment options available, the fundamental medical need presented by corneal neovascular pathologies remains unmet. In order to develop safe, effective, and targeted therapies, a reliable model of corneal NV and pharmacological intervention is required. Here, we describe an alkali-burn injury corneal neovascularization model in the mouse. This protocol provides a method for the application of a controlled alkali-burn injury to the cornea, administration of a pharmacological compound of interest, and visualization of the result. This method could prove instrumental for studying the mechanisms and opportunities for intervention in corneal NV and other neovascular disorders.

摘要

在正常情况下,角膜是无血管的,这种透明度对于维持良好的视力至关重要。角膜新生血管形成(NV)可由外伤、角膜移植术或传染病引起,它打破了角膜所谓的“血管生成特权”,并形成多种甚至可能导致失明的视觉病理的基础。尽管有几种治疗选择,但角膜新生血管病变所带来的基本医疗需求仍未得到满足。为了开发安全、有效且有针对性的疗法,需要一个可靠的角膜NV模型和药物干预模型。在此,我们描述一种小鼠碱烧伤诱导的角膜新生血管化模型。本方案提供了一种对角膜施加可控碱烧伤、给予感兴趣的药理化合物并观察结果的方法。该方法可能对研究角膜NV及其他新生血管疾病的干预机制和机会具有重要作用。

相似文献

1
An alkali-burn injury model of corneal neovascularization in the mouse.
J Vis Exp. 2014 Apr 7(86):51159. doi: 10.3791/51159.
4
Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4062-71. doi: 10.1167/iovs.04-1330.
7
A Mouse Model for Corneal Neovascularization by Alkali Burn.
J Vis Exp. 2023 Jun 30(196). doi: 10.3791/65289.
9
Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.
Exp Eye Res. 2021 Feb;203:108399. doi: 10.1016/j.exer.2020.108399. Epub 2020 Dec 23.
10
CXCR3 deletion aggravates corneal neovascularization in a corneal alkali-burn model.
Exp Eye Res. 2022 Dec;225:109265. doi: 10.1016/j.exer.2022.109265. Epub 2022 Oct 4.

引用本文的文献

1
Toll-like receptor 2 deficiency exacerbates corneal angiogenesis in injury by impairing regulatory T cells.
Theranostics. 2025 May 7;15(13):6082-6099. doi: 10.7150/thno.110322. eCollection 2025.
2
Modeling Neuropathic Corneal Pain: Pulled Nerve Approach With Elevated Krt16 Gene Expression.
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):35. doi: 10.1167/iovs.66.2.35.
3
Nanomedicine in Ophthalmology: From Bench to Bedside.
J Clin Med. 2024 Dec 16;13(24):7651. doi: 10.3390/jcm13247651.
4
Research progress on the correlation between corneal neovascularization and lymphangiogenesis (Review).
Mol Med Rep. 2025 Feb;31(2). doi: 10.3892/mmr.2024.13412. Epub 2024 Dec 5.
5
Silencing METTL3 Increases HSP70 Expression and Alleviates Fibrosis in Keratocytes.
Invest Ophthalmol Vis Sci. 2024 Nov 4;65(13):9. doi: 10.1167/iovs.65.13.9.
6
Neutrophil pyroptosis regulates corneal wound healing and post-injury neovascularisation.
Clin Transl Med. 2024 Nov;14(11):e1762. doi: 10.1002/ctm2.1762.
7
A chimeric anti-vascularization immunomodulator prevents high-risk corneal transplantation rejection via ex vivo gene therapy.
Mol Ther. 2024 Nov 6;32(11):4006-4020. doi: 10.1016/j.ymthe.2024.09.007. Epub 2024 Sep 7.
8
Conditional deletion of Zeb1 in Csf1r cells reduces inflammatory response of the cornea to alkali burn.
iScience. 2024 Apr 9;27(5):109694. doi: 10.1016/j.isci.2024.109694. eCollection 2024 May 17.
9
Corneal gene therapy: Structural and mechanistic understanding.
Ocul Surf. 2023 Jul;29:279-297. doi: 10.1016/j.jtos.2023.05.007. Epub 2023 May 25.
10
The CXCR4/miR-1910-5p/MMRN2 Axis Is Involved in Corneal Neovascularization by Affecting Vascular Permeability.
Invest Ophthalmol Vis Sci. 2023 Apr 3;64(4):10. doi: 10.1167/iovs.64.4.10.

本文引用的文献

1
The albino mutation of tyrosinase alters ocular angiogenic responsiveness.
Angiogenesis. 2013 Jul;16(3):639-46. doi: 10.1007/s10456-013-9342-0. Epub 2013 Feb 20.
2
Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring.
Invest Ophthalmol Vis Sci. 2013 Mar 1;54(3):1680-8. doi: 10.1167/iovs.12-10782.
4
Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Acta Ophthalmol. 2014 Mar;92(2):143-8. doi: 10.1111/j.1755-3768.2012.02525.x. Epub 2012 Sep 20.
5
b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.
Cornea. 2012 Jul;31(7):804-9. doi: 10.1097/ICO.0b013e31823f8b5a.
6
Global estimates of visual impairment: 2010.
Br J Ophthalmol. 2012 May;96(5):614-8. doi: 10.1136/bjophthalmol-2011-300539. Epub 2011 Dec 1.
8
Treatments for corneal neovascularization: a review.
Cornea. 2011 Aug;30(8):927-38. doi: 10.1097/ICO.0b013e318201405a.
9
Anatomy and physiology of the cornea.
J Cataract Refract Surg. 2011 Mar;37(3):588-98. doi: 10.1016/j.jcrs.2010.12.037.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验